Find Research Outputs

Search in all content

Filters for Research Output

Search concepts
Selected filters

Publication Year

  • 2020
  • 2019
  • 2018
  • 2017
  • 2016

Author

  • Wu-Chou Su
2016

Oncoprotein ZNF322A transcriptionally deregulates alpha-adducin, cyclin D1 and p53 to promote tumor growth and metastasis in lung cancer

Jen, J., Lin, L. L., Chen, H. T., Liao, S. Y., Lo, F. Y., Tang, Y. A., Su, W. C., Salgia, R., Hsu, C. L., Huang, H. C., Juan, H. F. & Wang, Y. C., 2016 May 5, In : Oncogene. 35, 18, p. 2357-2369 13 p.

Research output: Contribution to journalArticle

24 Citations (Scopus)

Vinflunine-gemcitabine versus vinflunine-carboplatin as first-line chemotherapy in cisplatin-unfit patients with advanced urothelial carcinoma: Results of an international randomized phase II trial (JASINT1)

De Santis, M., Wiechno, P. J., Bellmunt, J., Lucas, C., Su, W. C., Albiges, L., Lin, C. C., Senkus-Konefka, E., Flechon, A., Mourey, L., Necchi, A., Loidl, W. C., Retz, M. M., Vaissière, N. & Culine, S., 2016 Mar 1, In : Annals of Oncology. 27, 3, p. 449-454 6 p., mdv609.

Research output: Contribution to journalArticle

33 Citations (Scopus)
7 Citations (Scopus)
2019
Open Access
2017

Chronic treatment with cisplatin induces chemoresistance through the TIP60-mediated Fanconi anemia and homologous recombination repair pathways

Su, W. P., Ho, Y. C., Wu, C. K., Hsu, S. H., Shiu, J. L., Huang, J. C., Chang, S. B., Chiu, W. T., Hung, J. J., Liu, T. L., Wu, W. S., Wu, P. Y., Su, W. C., Chang, J. Y. & Liaw, H., 2017 Dec 1, In : Scientific reports. 7, 1, 3879.

Research output: Contribution to journalArticle

4 Citations (Scopus)
7 Citations (Scopus)
23 Citations (Scopus)

Chemotherapeutics-induced Oct4 expression contributes to drug resistance and tumor recurrence in bladder cancer

Lu, C. S., Shieh, G. S., Wang, C. T., Su, B. H., Su, Y. C., Chen, Y. C., Su, W. C., Wu, P., Yang, W. H., Shiau, A. L. & Wu, C. L., 2017, In : Oncotarget. 8, 19, p. 30844-30858 15 p.

Research output: Contribution to journalArticle

20 Citations (Scopus)

Cabozantinib in hepatocellular carcinoma: Results of a phase 2 placebo-controlled randomized discontinuation study

Kelley, R. K., Verslype, C., Cohn, A. L., Yang, T. S., Su, W. C., Burris, H., Braiteh, F., Vogelzang, N., Spira, A., Foster, P., Lee, Y. & Van Cutsem, E., 2017, In : Annals of Oncology. 28, 3, p. 528-534 7 p.

Research output: Contribution to journalArticle

58 Citations (Scopus)

Dysregulation of Rab37-mediated cross-talk between cancer cells and endothelial cells via thrombospondin-1 promotes tumor neovasculature and metastasis

Tzeng, H. T., Tsai, C. H., Yen, Y. T., Cheng, H. C., Chen, Y. C., Pu, S. W., Wang, Y. S., Shan, Y. S., Tseng, Y. L., Su, W. C., Lai, W. W., Wu, L. W. & Wang, Y. C., 2017 May 1, In : Clinical Cancer Research. 23, 9, p. 2335-2345 11 p.

Research output: Contribution to journalArticle

24 Citations (Scopus)

Association between GWAS-identified lung adenocarcinoma susceptibility loci and EGFR mutations in never-smoking Asian women, and comparison with findings from Western populations

Seow, W. J., Matsuo, K., Hsiung, C. A., Shiraishi, K., Song, M., NamKim, H., Wong, M. P., Hong, Y. C., Dean Hosgood, H., Wang, Z., Chang, I. S., Wang, J. C., Chatterjee, N., Tucker, M., Wei, H., Mitsudomi, T., Zheng, W., Kim, J. H., Zhou, B., Caporaso, N. E. & 166 others, Albanes, D., Shin, M. H., Chung, L. P., An, S. J., Wang, P., Zheng, H., Yatabe, Y., Zhang, X. C., Kim, Y. T., Shu, X. O., Kim, Y. C., Bassig, B. A., Chang, J., Man Ho, J. C., Ji, B. T., Kubo, M., Daigo, Y., Ito, H., Momozawa, Y., Ashikawa, K., Kamatani, Y., Honda, T., Sakamoto, H., Kunitoh, H., Tsuta, K., Watanabe, S. I., Nokihara, H., Miyagi, Y., Nakayama, H., Matsumoto, S., Tsuboi, M., Goto, K., Yin, Z., Shi, J., Takahashi, A., Goto, A., Minamiya, Y., Shimizu, K., Tanaka, K., Wu, T., Wei, F., Wong, J. Y. Y., Matsuda, F., Su, J., Kim, Y. H., Oh, I. J., Song, F., Lee, V. H. F., Su, W. C., Chen, Y. M., Chang, G. C., Chen, K. Y., Huang, M. S., Yang, P. C., Lin, H. C., Xiang, Y. B., Seow, A., Park, J. Y., Kweon, S. S., Chen, C. J., Li, H., Gao, Y. T., Wu, C., Qian, B., Lu, D., Liu, J., Jeon, H. S., Hsiao, C. F., Sung, J. S., Tsai, Y. H., Jung, Y. J., Guo, H., Hu, Z., Wang, W. C., Chung, C. C., Lawrence, C., Burdett, L., Yeager, M., Jacobs, K. B., Hutchinson, A., Berndt, S. I., He, X., Wu, W., Wang, J., Li, Y., Choi, J. E., Park, K. H., Sung, S. W., Liu, L., Kang, C. H., Hu, L., Chen, C. H., Yang, T. Y., Xu, J., Guan, P., Tan, W., Wang, C. L., Loon Sihoe, A. D., Chen, Y., Choi, Y. Y., Hung, J. Y., Kim, J. S., Yoon, H. I., Cai, Q., Lin, C. C., Park, I. K., Xu, P., Dong, J., Kim, C., He, Q., Perng, R. P., Chen, C. Y., Vermeulen, R., Wu, J., Lim, W. Y., Chen, K. C., Chan, J. K. C., Chu, M., Li, Y. J., Li, J., Chen, H., Yu, C. J., Jin, L., Lo, Y. L., Chen, Y. H., Fraumeni, J. F., Liu, J., Yamaji, T., Yang, Y., Hicks, B., Wyatt, K., Li, S. A., Dai, J., Ma, H., Jin, G., Song, B., Wang, Z., Cheng, S., Li, X., Ren, Y., Cui, P., Iwasaki, M., Shimazu, T., Tsugane, S., Zhu, J., Jiang, G., Fei, K., Wu, G., Chien, L. H., Chen, H. L., Su, Y. C., Tsai, F. Y., Chen, Y. S., Yu, J., Stevens, V. L., Laird-Offringa, I. A., Marconett, C. N., Lin, D., Chen, K., Wu, Y. L., Landi, M. T., Shen, H., Rothman, N., Kohno, T., Chanock, S. J. & Lan, Q., 2017, In : Human Molecular Genetics. 26, 2, p. 454-465 12 p.

Research output: Contribution to journalArticle

22 Citations (Scopus)
13 Citations (Scopus)
2018
7 Citations (Scopus)
2019

Pembrolizumab in Combination With Erlotinib or Gefitinib as First-Line Therapy for Advanced NSCLC With Sensitizing EGFR Mutation

Yang, J. C. H., Gadgeel, S. M., Sequist, L. V. D., Wu, C. L., Papadimitrakopoulou, V. A., Su, W. C., Fiore, J., Saraf, S., Raftopoulos, H. & Patnaik, A., 2019 Mar, In : Journal of Thoracic Oncology. 14, 3, p. 553-559 7 p.

Research output: Contribution to journalArticle

19 Citations (Scopus)
2018

EGFR mutation analysis for prospective patient selection in AURA3 phase III trial of osimertinib versus platinum-pemetrexed in patients with EGFR T790M-positive advanced non-small-cell lung cancer

John, T., Akamatsu, H., Delmonte, A., Su, W. C., Lee, J. S., Chang, G. C., Huang, X., Jenkins, S. & Wu, Y. L., 2018 Dec, In : Lung Cancer. 126, p. 133-138 6 p.

Research output: Contribution to journalArticle

7 Citations (Scopus)
2019

Psychometric evaluation of the WHOQOL-BREF, Taiwan version, across five kinds of Taiwanese cancer survivors: Rasch analysis and confirmatory factor analysis

Lin, C. Y., Hwang, J. S., Wang, W. C., Lai, W. W., Su, W. C., Wu, T. Y., Yao, G. & Wang, J. D., 2019 Jan, In : Journal of the Formosan Medical Association. 118, 1P2, p. 215-222 8 p.

Research output: Contribution to journalArticle

24 Citations (Scopus)
2018

Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study

ATLANTIC Investigators, 2018 Apr, In : The Lancet Oncology. 19, 4, p. 521-536 16 p.

Research output: Contribution to journalArticle

159 Citations (Scopus)
10 Citations (Scopus)

Phase Ib/II Study of Capmatinib (INC280) Plus Gefitinib after Failure of Epidermal Growth Factor Receptor (EGFR) Inhibitor Therapy in Patients with EGFR-Mutated, MET Factor-Dysregulated Non-Small-Cell Lung Cancer

Wu, Y. L., Zhang, L., Kim, D. W., Liu, X., Lee, D. H., Yang, J. C. H., Ahn, M. J., Vansteenkiste, J. F., Su, W. C., Felip, E., Chia, V., Glaser, S., Pultar, P., Zhao, S., Peng, B., Akimov, M. & Tan, D. S. W., 2018 Nov 1, In : Journal of Clinical Oncology. 36, 31, p. 3101-3109 9 p.

Research output: Contribution to journalArticle

63 Citations (Scopus)
2016

Elucidating Quantum Confinement in Graphene Oxide Dots Based on Excitation-Wavelength-Independent Photoluminescence

Yeh, T. F., Huang, W. L., Chung, C. J., Chiang, I. T., Chen, L. C., Chang, H. Y., Su, W. C., Cheng, C., Chen, S. J. & Teng, H., 2016 Jun 2, In : Journal of Physical Chemistry Letters. 7, 11, p. 2087-2092 6 p.

Research output: Contribution to journalArticle

75 Citations (Scopus)
2019

Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial

Nakagawa, K., Garon, E. B., Seto, T., Nishio, M., Ponce Aix, S., Paz-Ares, L., Chiu, C. H., Park, K., Novello, S., Nadal, E., Imamura, F., Yoh, K., Shih, J. Y., Au, K. H., Moro-Sibilot, D., Enatsu, S., Zimmermann, A., Frimodt-Moller, B., Visseren-Grul, C., Reck, M. & 96 others, Chu, Q., Cortot, A., Pujol, J. L., Fabre, E., Lamour, C., Bischoff, H., Kollmeier, J., Kimmich, M., Engel-Riedel, W., Hammerschmidt, S., Schütte, W., Syrigos, K., Ho, J. C. M., Au, K. H., Ardizzoni, A., Pasello, G., Gregorc, V., Del Conte, A., Galetta, D., Takahashi, T., Kumagai, T., Hotta, K., Goto, Y., Hosomi, Y., Sakai, H., Takiguchi, Y., Kim, Y. H., Kurata, T., Yamaguchi, H., Daga, H., Okamoto, I., Satouchi, M., Ikeda, S., Kasahara, K., Atagi, S., Azuma, K., Aoe, K., Horio, Y., Yamamoto, N., Tanaka, H., Watanabe, S., Nogami, N., Ozaki, T., Koyama, R., Hirashima, T., Kaneda, H., Tomii, K., Fujita, Y., Seike, M., Nishimura, N., Kato, T., Ichiki, M., Saka, H., Hirano, K., Nakahara, Y., Sugawara, S., Kim, S. W., Min, Y. J., Lee, H. W., Kang, J. H., An, H. J., Lee, K. H., Kim, J. S., Lee, G. W., Lee, S. Y., Alexandru, A., Udrea, A. A., Juan-Vidal, Ó., Nadal-Alforja, E., Gil-Bazo, I., Ponce-Aix, S., Rubio-Viqueira, B., Alonso Garcia, M., Felip Font, E., Fuentes Pradera, J., Coves Sarto, J., Lin, M. C., Su, W. C., Hsia, T. C., Chang, G. C., Wei, Y. F., Su, J., Cicin, I., Goksel, T., Harputluoglu, H., Ozyilkan, O., Henning, I., Popat, S., Hatcher, O., Mileham, K., Acoba, J., Garon, E., Jung, G., Raj, M., Martin, W. & Dakhil, S., 2019 Dec, In : The Lancet Oncology. 20, 12, p. 1655-1669 15 p.

Research output: Contribution to journalArticle

31 Citations (Scopus)

Real-world outcomes of NSCLC patients receiving tissue or circulating tumor DNA-guided osimertinib treatment

Su, P. L., Yang, S. C., Chen, Y. L., Wu, Y. L., Lin, C. Y., Chang, W. Y., Tseng, Y. L., Lai, W. W., Ho, C. L., Lin, C. C. & Su, W. C., 2019 Oct 1, In : Cancer medicine. 8, 13, p. 5939-5947 9 p.

Research output: Contribution to journalArticle

Open Access
1 Citation (Scopus)
2020

Predicting lung cancer occurrence in never-smoking females in Asia: TNSF-SQ, a prediction model

Chien, L. H., Chen, C. H., Chen, T. Y., Chang, G. C., Tsai, Y. H., Hsiao, C. F., Chen, K. Y., Su, W. C., Wang, W. C., Huang, M. S., Chen, Y. M., Chen, C. Y., Liang, S. K., Chen, C. Y., Wang, C. L., Lee, M. H., Chung, R. H., Tsai, F. Y., Hu, J. W., Katki, H. A. & 8 others, Chatterjee, N., Chanock, S. J., Rothman, N., Lan, Q., Yang, P. C., Chen, C. J., Chang, I. S. & Hsiung, C. A., 2020 Feb 1, In : Cancer Epidemiology Biomarkers and Prevention. 29, 2, p. 452-459 8 p.

Research output: Contribution to journalArticle

Open Access
1 Citation (Scopus)